Riskpilot← Back to searchSign inGet full accessTLS DEVELOPMENT AS
ASActiveOrg 919567783Tomteveien 33, 1618 FredrikstadRental and operating of own or leased real estate · NACE 6820Est. 20170 employees
Revenue 2024
NOK 1,6M
+2% vs 2023
EBITDA margin
80.6%
+2% vs 2023
Equity ratio
15.0%
Financial strength
Net profit 2024
NOK 322K
+20% vs 2023
| Revenue | NOK 1,6M | +2% |
| EBITDA | NOK 1,3M | +2% |
| Net profit | NOK 322K | +20% |
| Total assets | NOK 15,6M | +0% |
| Equity | NOK 2,3M | +16% |
| Employees | 0 | — |
Legal name
TLS DEVELOPMENT AS
Org number
919567783
Legal form
Aksjeselskap
NACE code
6820 · Rental and operating of own or leased real estate
Founded
14. september 2017
Share capital
NOK 500 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder alene. Styrets leder alene.
Company purpose
Kjøp, salg, utvikling og utleie av næringseiendom.
Address
Tomteveien 33, 1618 Fredrikstad
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 125 | 1 094 | 1 472 | 1 408 | 1 580 | 1 841 | 1 588 | 1 626 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −9 | 751 | 1 162 | 1 108 | 1 127 | 1 150 | 1 278 | 1 310 |
| Depreciation & amort. | −28 | −331 | −331 | −331 | −331 | −331 | −336 | −331 |
| EBIT | −36 | 420 | 831 | 777 | 796 | 819 | 942 | 979 |
| Net financials | −20 | −421 | −451 | −546 | −471 | −419 | −597 | −566 |
| Profit before tax | −56 | −1 | 380 | 230 | 324 | 400 | 344 | 413 |
| Tax | −0 | −0 | 71 | 51 | 71 | 88 | 76 | 91 |
| Net profit | −56 | −1 | 309 | 179 | 253 | 312 | 269 | 322 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 17 918 | 16 885 | 16 616 | 16 220 | 15 819 | 15 531 | 15 635 | 15 626 |
| Equity | 444 | 443 | 752 | 932 | 1 185 | 1 496 | 2 015 | 2 337 |
| Long-term debt | 17 100 | 16 140 | 15 551 | 14 984 | 14 330 | 10 182 | 9 960 | 9 587 |
| Short-term debt | 374 | 302 | 312 | 304 | 305 | 3 853 | 3 660 | 3 701 |
| Total debt | 17 474 | 16 442 | 15 863 | 15 288 | 14 634 | 14 034 | 13 620 | 13 289 |
EBITDA margin
80.6%
This company
15.8%
Market median
+410% vs market
20172024
Equity ratio
15.0%
This company
38.2%
Market median
-61% vs market
20172024
Return on equity
13.8%
This company
18.4%
Market median
+25% vs market
20172024
Net profit margin
19.8%
This company
8.1%
Market median
+144% vs market
20172024
Asset turnover
0.10×
This company
1.12×
Market median
-91% vs market
20172024
Debt / equity
5.69×
This company
0.62×
Market median
-818% vs market
20172024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AE Chief Executive Officer | Chief Executive Officer | 2017 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2017 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Partnermed Holding As | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Partnermed Holding As
TLS DEVELOPMENT AS Board members of TLS DEVELOPMENT AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Atle Eriksen | Chief Executive Officer | 0 companies |
| Lise Andrea Setterberg Nossen | Board of Directors | 0 companies |
| Trine-Lise Setterberg Andersen | Chairman | 0 companies |
| Frank Einar Melby | Board of Directors | 0 companies |
| Lasse Setterberg Andersen | Board of Directors | 0 companies |